Thursday, October 26, 2023

A Growing Problem, which is Potentially Contributing to Overdose Deaths

›
By:  Marcus J. Hopkins , ADAP Blog Guest Contributor, and Founder & Executive Director of the Appalachian Learning Initiative (APPLI) In...
Thursday, October 19, 2023

2023 Ryan White HIV/AIDS Program Biennial Report Now Available

›
By: Health Resources and Services Administration’s HIV/AIDS Bureau The Health Resources and Services Administration’s (HRSA) HIV/AIDS Bureau...
Thursday, October 12, 2023

When You’re Still Sick: Living with Long-COVID and HIV

›
By:  Marcus J. Hopkins , ADAP Blog Guest Contributor, and Founder & Executive Director of the Appalachian Learning Initiative (APPLI) Re...
Thursday, October 5, 2023

Fireside Chat Retreat in Philadelphia, PA Tackles Pressing Public Health Issues

›
By:  Brandon M. Macsata , CEO, ADAP Advocacy ADAP Advocacy hosted its "Health Fireside Chat" retreat in Philadelphia, Pennsylvania...
Thursday, September 28, 2023

Tell HIV Stigma: Stay in Your Lane

›
By:  Brandon M. Macsata , CEO, ADAP Advocacy Association ****Important Support Resources Included**** Recently, I posted some commentary on ...
Thursday, September 21, 2023

340B Hypocrisy: The Inconvenient Truth Behind Why We Need to Reform This Vital Safety Net Program

›
By: Brandon M. Macsata, CEO, ADAP Advocacy        Jen Laws, President & CEO, Community Access National Network The 340B Drug Pricing Pro...
Thursday, September 14, 2023

New Study Dissects Efficacy of Lenacapavir

›
By:  Ranier Simons , ADAP Blog Guest Contributor Lenacapavir, a novel HIV treatment medication, again appears in the medical news cycle. A r...